Latest Headlines

Latest Headlines

WHO adopts new safety needle policy, calling smart syringes an 'urgent priority'

Citing rampant use of the same needle to inject more than one person, the World Health Organization has--some might say finally--launched a new policy to make unsafe injections less prevalent. Part of this policy involves adopting up-to-date measures in syringe engineering, promoting the use of "smart" needles with precautions against unsafe use.

Vaxxas' nanopatch garners WHO support in search of polio vax application

Australian nanopatch developer Vaxxas signed on with the World Health Organization this week in an effort to co-opt the company's patch for use with the polio vaccine. The WHO will help fund the research and move it through preclinical and clinical studies as the organization seeks to make polio a thing of the past.

Counterfeit antibiotics feed drug resistance, superbugs

The World Health Organization says counterfeit and substandard antibiotics are getting into the global supply chain and creating resistance to treatments while fueling the emergence of so-called superbugs.

WHO's links to ICH under fire amid efforts to strengthen manufacturing regulations

To the casual observer, the International Conference on Harmonisation (ICH) could appear to be a fusty but uncontroversial group. Yet ICH's position in the highly charged debate over how quality standards affect the cost and availability of drugs--coupled with its links to the pharma industry--have made it a target of criticism.

Sanofi's Shantha Biotechnics gets manufacturing issues resolved

Sanofi said Monday that WHO inspectors have signed off on Shantha Biotechnics' plant in Hyderabad, India. The agency has reviewed comprehensive data about the process and the product characteristics, and tagged its Shan5 with a prequalification. 

Sanofi's Shan5 overcomes manufacturing setback to score thumbs up from WHO

Four years after manufacturing problems cost Sanofi-owned Shantha Biotechnics a $340 million contract to supply pentavalent vaccine Shan5, the jab has rewon the World Health Organization's favor, nabbing a positive prequalification decision that opens the door for purchases by United Nations agencies.

Global measles deaths have dropped 78% since 2000

Since 2000, the Measles & Rubella Initiative has vaccinated 1 billion children in mass immunization campaigns.

WHO updates malaria roadmap with 2030 vaccine goals

When the World Health Organization released its first malaria vaccine technology roadmap in 2006, it put the development of a partly effective vaccine by 2015 at the top of its list of priorities. With GlaxoSmithKline nearing that goal, WHO has revised its plan with new targets for 2030.

WHO massively scales up Middle East polio immunization plan

The polio outbreak in Syria has the World Health Organization worried. Just weeks after outlining a two-month, 10-million dose vaccination campaign, the United Nations' public health arm has escalated its plans. The new goal is to vaccinate 50 million kids across the Middle East over the next 8 months.

IOM releases modeling software for vaccine prioritization

Using World Health Organization data, the software builds models to estimate the lives a vaccine could save and the likelihood of it being profitable.